Lannett launches generic Advair Diskus in US
Aurobindo Pharma USA subsidiary introduces fluticasone propionate and salmeterol inhalation powder in two strengths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
USFDA classifies Aurobindo Pharma’s Raleigh plant as VAI
The facility received 11 observations during the USFDA inspection conducted from March 24 to April 10, 2025
Accessibility through agility: Building manufacturing and access systems that deliver affordable…
Across the pharmaceutical industry, one thing is clear: being efficient doesn't make medicines affordable on its own.…
Aurobindo Pharma USA completes acquisition of Lannett following US FTC approval
Lannett becomes wholly owned subsidiary of APUSA and will operate as Lannett Company LLC from June 29, 2026
Building India Pharma Inc’s innovation muscle
While we agree that “what got us here (an affordable generics powerhouse) will not get us there (a leader in pharma innovation)”,…
Turning the tariff tight spot into a sweet spot
US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…
Panel Discussion: Aligning packaging strategies with R&D
At the recently held PPL Conclave 2025 in Hyderabad, a panel discussion titled "Aligning Packaging Strategies with R&D"…
Panel Discussion – Patient-centric packaging: Safe, Smart, Secure
PPL Conclave 2025 witnessed several compelling panel discussions. One of them was on 'Patient-centric packaging: Safe, Smart,…
Eugia gets USFDA warning letter for Unit-3 in Pashamylaram
Eugia Pharma is a wholly-owned subsidiary of Hyderabad-based drug manufacturer, Aurobindo Pharma
Eugia Pharma gets USFDA nod for posaconazole injection, 300 mg/16.7 mL, single-dose vial
The approved product has an estimated market size of $25.4 million for the twelve months ending October 2023, according to IQVIA